Also listed on G and L Consulting LLC, which filed it. The recorded assignments below show how it moved.
Term ends Jul 13, 2029
Statutory term ends Mar 1, 2026
Base term plus 1230 days of PTA
Today
20y-from-earliest-nonprovisional
Expires Jul 2029
2006
2029
Clock starts
Mar 1, 2006
Mar 1, 2006
Granted
Apr 24, 2012
Apr 24, 2012
Term ends
Jul 13, 2029
Jul 13, 2029
base term
patent term adjustment
fee events
Computed Sep 1, 2026 · countdowns run from that date · how we know
1,230
Days of PTA
1
Applications in this family
This patent's term runs 1230 days past the statutory base term on prosecution delay. All three maintenance fees are paid, so nothing but the term itself will end it. Confidence: High. from the record
How this date was computed
Every step shows its rule, its input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20y-from-earliest-nonprovisional | Clock starts Mar 1, 2006 | Mar 1, 2026 | High |
| Continuity chain | Every parent in the chain resolved | no change | High |
| Patent term adjustment | +1230 days, USPTO PTA record | Jul 13, 2029 | High |
| Terminal disclaimer cap | None on record | no cap applied | High |
| Patent term extension | None on file | no change | High |
| Fee events | 3 of 3 maintenance fees paid | in-force | High |
| Computed term end | The steps above, in order | Jul 13, 2029 | High |
The computation, verbatim
base=20y-from-earliest-nonprovisional: 2006-03-01+20y | =2026-03-01 | PTA+1230d=2029-07-13 | PTE:none | TD:none | paid 4yr@2015-10-19,8yr@2019-10-24,12yr@2023-10-24 | status=in-force@2029-07-13
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Mar 13, 2006 reel/frame not recorded | Gelfand, Mark; Levin, Howard | G&l Consulting LLC | Assignment of Assignor's Interest |
| Dec 23, 2011 reel/frame not recorded | G&l Consulting, LLC | Backbeat Medical, Inc. | Assignment of Assignor's Interest |
| Feb 13, 2020 reel/frame not recorded | Backbeat Medical, Inc. | Backbeat Medical, LLC | Entity Conversion |
| Jun 6, 2022 reel/frame not recorded | Accelerated Technologies, Inc.; Backbeat Medical, LLC; Caliber Therapeutics, LLC; Freehold Surgical, LLC; Orchestra Biomed, Inc. | Avenue Venture Opportunities Fund, L.P., as Agent | Security Agreement |
| Oct 9, 2023 reel/frame not recorded | Avenue Venture Opportunities Fund, L.P. | Orchestra Biomed, Inc. | Release of Ip Security Interest |
| Oct 9, 2023 reel/frame not recorded | Avenue Venture Opportunities Fund, L.P. | Caliber Therapeutics, LLC | Release of Ip Security Interest |
| Oct 9, 2023 reel/frame not recorded | Avenue Venture Opportunities Fund, L.P. | Backbeat Medical, LLC | Release of Ip Security Interest |
| Oct 9, 2023 reel/frame not recorded | Avenue Venture Opportunities Fund, L.P. | Freehold Surgical, LLC | Release of Ip Security Interest |
| Oct 9, 2023 reel/frame not recorded | Avenue Venture Opportunities Fund, L.P. | Accelerated Technologies, Inc. | Release of Ip Security Interest |
| Nov 6, 2024 reel/frame not recorded | Backbeat Medical, LLC; Caliber Therapeutics, LLC; Freehold Surgical, LLC; Orchestra Biomed Holdings, Inc.; Orchestra Biomed, Inc. | Hercules Capital, Inc. | Security Interest |
| Aug 4, 2025 reel/frame not recorded | Backbeat Medical, LLC; Caliber Therapeutics, LLC; Orchestra Biomed Holdings, Inc.; Orchestra Biomed, Inc. | Ligand Pharmaceuticals, Inc. | Security Interest |
| Aug 7, 2025 reel/frame not recorded | Backbeat Medical, LLC; Caliber Therapeutics, LLC; Orchestra Biomed Holdings, Inc.; Orchestra Biomed, Inc. | Medtronic, Inc. | Security Interest |
Free plan: 3 watched companies. Pro: unlimited.
alerts on grants, lapses, transfers
Is this your company? Verify this record
What's changing
Jul 2029
Term ends. No further fees fall due before then
Note
The 1230 days of PTA are read from the USPTO record, not recalculated by us
Citations
0
later US patents cite this one
That is below the median of utility patents granted in 2012 in our data, the only group it is compared against.
How we rank
Every date shows its work: base rule, PTA, PTE, disclaimer caps, fee overlay, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.